Defended AstraZeneca in a breach of contract and theft of trade secrets case. The Plaintiff alleged that AstraZeneca made unauthorized use of genetic databases after an agreement between the companies ended in 2004. Agreeing with our argument that the Plaintiff ignored its suspicion that AstraZeneca had breached the contract for six years, the Superior Court in granted our request for summary judgment on the grounds that the claims are time-barred and the Delaware Supreme Court upheld the decision.